Novartis Oncology Investor Relations Salaries in Wilmington, DE | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Investor Relations Salaries in Wilmington, DE

The average Novartis Oncology Investor Relations in Wilmington, DE earns an estimated $57,825 annually. Novartis Oncology's Investor Relations compensation is $24,106 less than the US average for a Investor Relations.

In Wilmington, DE, The Communications Department at Novartis Oncology earns $10,872 more on average than the Product Department.

Last updated 3 years ago.

$35k
$47k
$63k
$70k
$109k
$139k
$168k
$57,825
Average Compensation
$57,825
avg. base

Investor Relations Salaries at Novartis Oncology

* estimated salary

Compensation at Novartis Oncology by Department

In Wilmington, DE, The Communications Department averages $10,872 more than the Product Department, and $436 less than the Enterprise Risk Department

Enterprise Risk
$186,276 Avg. total comp.
+$436
Communications
$185,840 Avg. total comp.
Product
$174,968 Avg. total comp.
-$11k

Investor Relations Compensation by Gender (All Companies)

The average female Investor Relations at companies similar size to Novartis Oncology reported making $155,000, while the average male Investor Relations at similar sized companies reported making $50,000.

How Investor Relations at Novartis Oncology Rate Their Compensation

The majority of Investor Relations at Novartis Oncology believe they're not compensated fairly. 100% of Investor Relations at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company